Entrada Therapeutics, Inc.

By person

16 insiders · 282 transactions

5.8×

Dipal Doshi holds 5.8 times base salary in stock. $3.69M of shares against $635.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dipal Doshi last reported holding, valued at $7.13, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Redmile Group, LLC entity

10% owner

$20.00M (1)

—

+$20.00M

1,954,420

5.02%

$13.94M

—

BAKER BROS. ADVISORS LP entity

10% owner

$2.59M (40)

—

+$2.59M

4,691,392

12.05%

$33.45M

+8.5%

MPM BioVentures 2014, L.P.

10% owner

$2.00M (1)

$4.52M (14)

−$2.52M

8,203,463

21.07%

$58.49M

+90.0%

MPM BIOVENTURES 2018, L.P.

10% owner

$2.00M (1)

$4.52M (14)

−$2.52M

8,203,463

21.07%

$58.49M

+90.0%

Foley Todd

Director

$2.00M (1)

—

+$2.00M

4,425,784

11.37%

$31.56M

—

WENTWORTH KORY JAMES

Chief Financial Officer

—

$1.91M (37) scheduled

−$1.91M

117,277

0.3012%

$836.19K

—

Sethuraman Natarajan

President, Research & Develop.

—

$1.90M (21) scheduled

−$1.90M

214,238

0.5502%

$1.53M

+64.1%

Dowden Nathan J

President & COO

—

$1.90M (31) scheduled

−$1.90M

196,060

0.5035%

$1.40M

+315.9%

Doshi Dipal

CEO

—

$1.39M (49)

−$1.39M

517,290

1.33%

$3.69M

+314.5%

KREHER NERISSA

Chief Medical Officer

—

$998.17K (24) scheduled

−$998.17K

40,037

0.1028%

$285.46K

—

5AM Ventures V, L.P. entity

10% owner

$5.00M (1)

$4.07M (13)

+$931.96K

3,877,094

9.96%

$27.64M

+1,071%

KIM PETER S

Director

$641.94K (11)

—

+$641.94K

104,330

0.2679%

$743.87K

+121.8%

PARMAR KUSH

Director

$5.00M (1)

$4.72M (14)

+$284.85K

2,691,337

6.91%

$19.19M

—

Crowley John F

Director

$48.58K (1)

—

+$48.58K

5,000

0.0128%

$35.65K

—

Zeiher Bernhardt G

Director

$29.32K (1)

—

+$29.32K

5,000

0.0128%

$35.65K

—

ROCHE HOLDING LTD entity

10% owner

—

2,813,525

7.23%

$20.06M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

WENTWORTH KORY JAMES

3 Apr 2025

Chief Financial Officer

Exercised, kept

11,134

$2.10

$23.38K

KIM PETER S

3 Jun 2024

Director

Exercised, kept

11,918

$6.06

$72.22K

WENTWORTH KORY JAMES

15 Mar 2024

Chief Financial Officer

Exercised, kept

9,000

$2.10

$18.90K

WENTWORTH KORY JAMES

29 Jun 2023

Chief Financial Officer

Exercised, kept

8,790

$2.10

$18.46K

Showing 250 of 282 transactions. The figures above use every one of them.

Entrada Therapeutics, Inc.

By person

Individual transactions

What was left out